UK: +44 (0) 1283 753 220
US: +1 908 829 4146
EMAS Pharma provides specialist drug development services that maximize speed to market and optimize commercialization post-approval, right to the end of product life-cycle. This is all with the purpose of discovering improved methods of treating patients.
A key measure of the success of our services is the shortening of drug development time, which means that patients receive innovative medicines as early as possible. Our clients benefit commercially by taking advantage of maximum patent life and a comprehensive clinical evidence base to support product marketing.
We bring decades of experience and offer insight from the perspective of big and small pharma, biotech, medical device and regulatory authority perspectives. Our track record demonstrates consistent success in implementing clinical research, medical affairs, pharmacovigilance and regulatory affairs worldwide.
We aim to build long term, mutually beneficial partnerships with our clients. We practice the following values in delivering our service:
Chief Executive Officer, EMAS Pharma
+44 (0)1462 424400
All rights reserved © 2017 Bionical Ltd.